OBI Pharma, Inc.
id:
obi-pharma-inc-300-10021561
title:
OBI Pharma, Inc.
text:
OBI Pharma, Inc. is a bio-pharmaceutical company, based in Nangang District, Taipei, Taiwan. In 2018 it announced that its drug, OBI-3424, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of Hepatocellular Carcinoma (HCC).
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/OBI_Pharma,_Inc.
date created:
date modified:
2024-04-24T09:53:50Z
main entity:
{"identifier":"Q23766534","url":"https://www.wikidata.org/entity/Q23766534"}
image:
fields total:
13
integrity:
13